公开(公告)号：US11738012B2

公开(公告)日：2023-08-29

申请号：US16078929

申请日：2017-02-24

Applicant: PRILENIA NEUROTHERAPEUTICS LTD.

Inventor： Hermann Kurt Russ ,  Michal Geva ,  Ralph Laufer ,  Aric Orbach

IPC: A61K31/451 ,  A61K45/06 ,  A61P27/02 ,  A61P27/06

CPC classification number: A61K31/451 ,  A61K45/06 ,  A61P27/02 ,  A61P27/06

Abstract: The subject invention provides a method of treating a subject afflicted with a neurodegenerative eye disease comprising administering to the subject an amount of pridopidine effective to treat the subject.

公开(公告)号：US20220062255A1

公开(公告)日：2022-03-03

申请号：US17513239

申请日：2021-10-28

Applicant: PRILENIA NEUROTHERAPEUTICS LTD.

Inventor： Michal Geva ,  Hermann Kurt Russ ,  Ralph Laufer ,  Aric Orbach

IPC: A61K31/451 ,  A61P27/06 ,  A61K9/00

Abstract: This application provides a method of treating a subject afflicted with a neurodegenerative eye disease comprising administering to the subject an amount of pridopidine effective to treat the subject, pharmaceutical composition and uses and applications thereof.